NATIONAL HEALTHCARE CORP (NHC) Fundamental Analysis & Valuation
NYSEARCA:NHC • US6359061008
Current stock price
158.81 USD
+1.08 (+0.68%)
At close:
158.808 USD
0 (0%)
After Hours:
This NHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NHC Profitability Analysis
1.1 Basic Checks
- NHC had positive earnings in the past year.
- In the past year NHC had a positive cash flow from operations.
- NHC had positive earnings in each of the past 5 years.
- In the past 5 years NHC always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.86%, NHC belongs to the top of the industry, outperforming 89.11% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 11.23%, NHC is in the better half of the industry, outperforming 74.26% of the companies in the same industry.
- With a decent Return On Invested Capital value of 7.58%, NHC is doing good in the industry, outperforming 70.30% of the companies in the same industry.
- NHC had an Average Return On Invested Capital over the past 3 years of 5.59%. This is below the industry average of 8.94%.
- The last Return On Invested Capital (7.58%) for NHC is above the 3 year average (5.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.86% | ||
| ROE | 11.23% | ||
| ROIC | 7.58% |
ROA(3y)6.55%
ROA(5y)6.26%
ROE(3y)9.66%
ROE(5y)9.38%
ROIC(3y)5.59%
ROIC(5y)4.83%
1.3 Margins
- With an excellent Profit Margin value of 7.91%, NHC belongs to the best of the industry, outperforming 88.12% of the companies in the same industry.
- In the last couple of years the Profit Margin of NHC has grown nicely.
- With a decent Operating Margin value of 8.46%, NHC is doing good in the industry, outperforming 75.25% of the companies in the same industry.
- NHC's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 39.31%, NHC is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
- NHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.46% | ||
| PM (TTM) | 7.91% | ||
| GM | 39.31% |
OM growth 3Y47.3%
OM growth 5Y-2.21%
PM growth 3Y56.39%
PM growth 5Y14.19%
GM growth 3Y2.23%
GM growth 5Y-1.42%
2. NHC Health Analysis
2.1 Basic Checks
- NHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for NHC has been increased compared to 1 year ago.
- Compared to 5 years ago, NHC has more shares outstanding
- The debt/assets ratio for NHC has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 5.41 indicates that NHC is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 5.41, NHC belongs to the top of the industry, outperforming 88.12% of the companies in the same industry.
- NHC has a debt to FCF ratio of 0.27. This is a very positive value and a sign of high solvency as it would only need 0.27 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 0.27, NHC belongs to the best of the industry, outperforming 92.08% of the companies in the same industry.
- NHC has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.03, NHC belongs to the top of the industry, outperforming 82.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.27 | ||
| Altman-Z | 5.41 |
ROIC/WACC0.86
WACC8.8%
2.3 Liquidity
- NHC has a Current Ratio of 1.82. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
- NHC has a better Current ratio (1.82) than 75.25% of its industry peers.
- A Quick Ratio of 1.79 indicates that NHC should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.79, NHC is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.79 |
3. NHC Growth Analysis
3.1 Past
- NHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.38%, which is quite good.
- Measured over the past years, NHC shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.00% on average per year.
- The Revenue has grown by 16.09% in the past year. This is quite good.
- The Revenue has been growing by 8.10% on average over the past years. This is quite good.
EPS 1Y (TTM)17.38%
EPS 3Y74.12%
EPS 5Y23%
EPS Q2Q%306.54%
Revenue 1Y (TTM)16.09%
Revenue growth 3Y11.81%
Revenue growth 5Y8.1%
Sales Q2Q%4.65%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. NHC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 20.71, which indicates a rather expensive current valuation of NHC.
- 65.35% of the companies in the same industry are more expensive than NHC, based on the Price/Earnings ratio.
- NHC's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.73.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.71 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NHC is valued a bit cheaper than 65.35% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, NHC is valued a bit cheaper than 67.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.6 | ||
| EV/EBITDA | 11.96 |
4.3 Compensation for Growth
- The decent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.9
EPS Next 2YN/A
EPS Next 3YN/A
5. NHC Dividend Analysis
5.1 Amount
- NHC has a Yearly Dividend Yield of 1.64%.
- Compared to an average industry Dividend Yield of 0.50, NHC pays a better dividend. On top of this NHC pays more dividend than 89.11% of the companies listed in the same industry.
- NHC's Dividend Yield is comparable with the S&P500 average which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
5.2 History
- The dividend of NHC has a limited annual growth rate of 3.74%.
- NHC has been paying a dividend for at least 10 years, so it has a reliable track record.
- NHC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.74%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
- NHC pays out 32.25% of its income as dividend. This is a sustainable payout ratio.
- The dividend of NHC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP32.25%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Fundamentals: All Metrics, Ratios and Statistics
158.81
+1.08 (+0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2026-02-25
Earnings (Next)05-06 2026-05-06
Inst Owners64.91%
Inst Owner Change3.98%
Ins Owners7.03%
Ins Owner Change0.72%
Market Cap2.47B
Revenue(TTM)1.52B
Net Income(TTM)120.02M
Analysts60
Price TargetN/A
Short Float %3.79%
Short Ratio6.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
Yearly Dividend2.5
Dividend Growth(5Y)3.74%
DP32.25%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-31 2026-03-31 (0.64)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.71 | ||
| Fwd PE | N/A | ||
| P/S | 1.63 | ||
| P/FCF | 16.6 | ||
| P/OCF | 13.33 | ||
| P/B | 2.31 | ||
| P/tB | 2.81 | ||
| EV/EBITDA | 11.96 |
EPS(TTM)7.67
EY4.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.56
FCFY6.02%
OCF(TTM)11.91
OCFY7.5%
SpS97.67
BVpS68.78
TBVpS56.53
PEG (NY)N/A
PEG (5Y)0.9
Graham Number108.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.86% | ||
| ROE | 11.23% | ||
| ROCE | 10.08% | ||
| ROIC | 7.58% | ||
| ROICexc | 9.49% | ||
| ROICexgc | 11.67% | ||
| OM | 8.46% | ||
| PM (TTM) | 7.91% | ||
| GM | 39.31% | ||
| FCFM | 9.79% |
ROA(3y)6.55%
ROA(5y)6.26%
ROE(3y)9.66%
ROE(5y)9.38%
ROIC(3y)5.59%
ROIC(5y)4.83%
ROICexc(3y)6.91%
ROICexc(5y)6.01%
ROICexgc(3y)8.5%
ROICexgc(5y)7.43%
ROCE(3y)7.43%
ROCE(5y)6.42%
ROICexgc growth 3Y57.26%
ROICexgc growth 5Y3.29%
ROICexc growth 3Y57.83%
ROICexc growth 5Y-0.34%
OM growth 3Y47.3%
OM growth 5Y-2.21%
PM growth 3Y56.39%
PM growth 5Y14.19%
GM growth 3Y2.23%
GM growth 5Y-1.42%
F-Score9
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.27 | ||
| Debt/EBITDA | 0.19 | ||
| Cap/Depr | 81.14% | ||
| Cap/Sales | 2.4% | ||
| Interest Coverage | 18.26 | ||
| Cash Conversion | 106.81% | ||
| Profit Quality | 123.85% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.79 | ||
| Altman-Z | 5.41 |
F-Score9
WACC8.8%
ROIC/WACC0.86
Cap/Depr(3y)71.08%
Cap/Depr(5y)76.94%
Cap/Sales(3y)2.32%
Cap/Sales(5y)2.68%
Profit Quality(3y)108.92%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.38%
EPS 3Y74.12%
EPS 5Y23%
EPS Q2Q%306.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.09%
Revenue growth 3Y11.81%
Revenue growth 5Y8.1%
Sales Q2Q%4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.78%
EBIT growth 3Y64.7%
EBIT growth 5Y5.71%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.48%
FCF growth 3YN/A
FCF growth 5Y-3.9%
OCF growth 1Y72.48%
OCF growth 3Y176.64%
OCF growth 5Y-1.86%
NATIONAL HEALTHCARE CORP / NHC Fundamental Analysis FAQ
What is the fundamental rating for NHC stock?
ChartMill assigns a fundamental rating of 6 / 10 to NHC.
Can you provide the valuation status for NATIONAL HEALTHCARE CORP?
ChartMill assigns a valuation rating of 3 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Overvalued.
How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?
NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 7 / 10.
How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?
The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 32.25%.